Industry News
Week of July 23, 2012: Amicus Therapeutics, GSK Expand Fabry Pact; US District Court Rules in Favor of Pfizer, Northwestern University in Lyrica Patent Case; and More
Amicus Therapeutics, GSK Expand Fabry Pact; US District Court Rules in Favor of Pfizer, Northwestern University in Lyrica Patent Case; and More.
Week of July 16, 2012: Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals; FDA Approves Gilead's Truvada for Reducing the Risk of Acquiring HIV; and More
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals; FDA Approves Gilead's Truvada for Reducing the Risk of Acquiring HIV; and More.
Week of July 9, 2012: Amgen Completes Acquisition of KAI Pharmaceuticals; Renaissance Acquisition Holdings Acquires DPT Laboratories; and More
Amgen Completes Acquisition of KAI Pharmaceuticals; Renaissance Acquisition Holdings Acquires DPT Laboratories; and More.
Week of July 2, 2012: GSK Extends Deadline for Tender Offer to Acquire Human Genome Services; Sartorius Opens New Filter, Aseptic-Bag Production Facility in Puerto Rico; and More
GSK Extends Deadline for Tender Offer to Acquire Human Genome Services; Sartorius Opens New Filter, Aseptic-Bag Production Facility in Puerto Rico; and More.
Week of June 25, 2012: Bend Research, Catalent Enter into Oral Controlled-Release Technologies Pact; Quintiles Expands in China; and More
Bend Research, Catalent Enter into Oral Controlled-Release Technologies Pact; Quintiles Expands in China; and More.
Week of June 18, 2012: US District Court for NJ Rules Against Merck & Co. in Nasonex Patent Infringement Case; FDA Issues Complete Response Letter to Pfizer for Tafamidis Meglumine NDA; and More
US District Court for NJ Rules Against Merck & Co. in Nasonex Patent Infringement Case; FDA Issues Complete Response Letter to Pfizer for Tafamidis Meglumine NDA; and More.
Week of June 11, 2012: Basilea, Stiefel Enter into Hand-Eczema Treatment Pact; Sandoz Recalls Generic Oral Contraceptive Drug; and More
Basilea, Stiefel Enter into Hand-Eczema Pact; Sandoz Recalls Generic Oral Contraceptive Drug; and More.
Week of June 4, 2012: Catalent Expands Fill–Finish Capabilities; Siegfried Acquires Alliance Medical Products; and More
Catalent Expands Fill–Finish Capabilities; Siegfried Acquires Alliance Medical Products; and More.
Week of May 28, 2012: Astra Zeneca, GlaxoSmithKline Enter into Antibiotics Pact; Takeda to Acquire Multilab; and More
Astra Zeneca, GlaxoSmithKline Enter into Antibiotics Pact; Takeda to Acquire Multilab; and More.
Week of May 21, 2012: FDA Approves BMS's New Bulk Biologics Manufacturing Facility; SGS Acquires Vitrology; and More
GSK Agrees to Acquire Cellzome; Patheon Restructures; and More.
Week of May 14, 2012: GSK Agrees to Acquire Cellzome; Patheon Restructures; and More
Week of May 7, 2012: Coherus BioSciences, Daiichi Sankyo Form Biosimilar Pact; Sandoz Agrees to Acquire Fougera Pharmaceuticals; and More
Coherus BioSciences, Daiichi Sankyo Form Biosimilar Pact; Sandoz Agrees to Acquire Fougera Pharmaceuticals; and More.
Week of Apr. 30, 2012: AstraZeneca's CEO David Brennan to Retire; PRA, Amgen Reach New Biosimilar Agreement; and More
AstraZeneca's CEO David Brennan To Retire; PRA, Amgen Reach New Biosimilar Agreement; and More.
Week of Apr. 23, 2012: AstraZeneca to Acquire Ardea Biosciences; Pfizer to Divest Nutrition Business to Nestlé; and More
AstraZeneca to Acquire Ardea Biosciences; Pfizer to Divest Nutrition Business to Nestlé; and More.
Week of Apr. 16, 2012: Merck & Co., Endocyte Form Development Pact; West Pharma Adds to NovaPure Brand; and More
Amgen to Acquire KAI Pharmaceuticals; BASF, Catalent Enter into Bioavailability Collaboration; and More.
Week of Apr. 9, 2012: Amgen to Acquire KAI Pharmaceuticals; BASF, Catalent Enter into Bioavailability Collaboration; and More
Week of Apr. 2, 2012: Amgen, AstraZeneca Agree to Codevelop Monoclonal Antibodies; Fujifilm Diosynth Biotechnologies Expands R&D Capabilities at its UK Site; and More
Amgen, AstraZeneca Agree to Codevelop Monoclonal Antibodies; Fujifilm Diosynth Biotechnologies Expands R&D Capabilities at its UK Site; and More.
Week of Mar. 26, 2012: Catalent Completes UK Expansion; Novasep Opens New Facility in China; and More
Catalent Completes UK Expansion; Novasep Opens New Facility in China; and More.
Week of Mar. 19, 2012: FDA Issues Warning Letter to Warner Chilcott; Sigma-Aldrich Expands in Asia; and More
FDA Issues Warning Letter to Warner Chilcott; Sigma-Aldrich Expands in Asia; and More.
Week of Mar. 12, 2012: AstraZeneca Files Suit Against FDA; Pfizer, Biocon Terminate Biosimilar Alliance; and More
AstraZeneca Files Suit Against FDA; Pfizer, Biocon Terminate Biosimilar Alliance; and More.
Week of Mar. 5, 2012: BASi Restructures; Celerion, Ricerca Biosciences Form Biosimilars Alliance; and More
BASi Restructures; Celerion, Ricerca Biosciences Form Biosimilars Alliance; and More.
Week of Feb. 27, 2012: JHS Secures Four Sterile Parenteral Products Manufacturing Contracts; Samsung Biologics, Biogen Idec Establish Biosimilars Joint Venture; and More
JHS Secures Four Sterile Parenteral Products Manufacturing Contracts; Samsung Biologics, Biogen Idec Establish Biosimilars Joint Venture; and More.
Week of Feb. 20, 2012: Biogen Idec to Acquire Stromedix; Mylan, Pfizer Announce Epinephrine Autoinjector Settlement Agreement; and More
Biogen Idec to Acquire Stromedix; Mylan, Pfizer Announce Epinephrine Autoinjector Settlement Agreement; and More.
Week of Feb. 13, 2012: Alexion Completes Acquisition of Enobia Pharma; BMS Completes Acquisition of Inhibitex; and More
Alexion Completes Acquisition of Enobia Pharma; BMS Completes Acquisition of Inhibitex; and More.
Week of Feb. 6, 2012: AstraZeneca Restructures; Catalent Completes Expansion in Italy; and More
AstraZeneca Restructures; Catalent Completes Expansion in Italy; and More.
Week of Jan. 30, 2012: Amgen Agrees to Micromet for $1.16 Billion; Cephalon Issues Recall of Treanda; and More
Amgen Agrees to Micromet for $1.16 Billion; Cephalon Issues Recall of Treanda; and More.
Week of Jan. 23, 2012: 2012 Facility of the Year Awards are Announced; Suzhou Pharma Services Names Oliver Mueller President; and More
2012 Facility of the Year Awards are Announced; Suzhou Pharma Services Names Oliver Mueller President; and More.
Week of Jan. 16, 2012: Takeda Restructures; Savient Pharmaceuticals Names David Veitch President of Savient Europe; and More
Takeda Restructures; Savient Pharmaceuticals Names David Veitch President of Savient Europe; and More.
Week of Jan. 9, 2012: Xoma Restructures; AAIPharma Appoints Eric Evans as CFO; and More
Xoma Restructures; AAIPharma Appoints Eric Evans as CFO; and More.
Week of Jan. 2, 2012: AMRI Restructures; ISPE Appoints Nancy S. Berg as CEO; and More
AMRI Restructures; ISPE Appoints Nancy S. Berg as CEO; and More.
